Literature DB >> 22495827

Interstitial brachytherapy for lower lip carcinoma: global assessment in a retrospective study of 89 cases.

Emmanuel Rio1, Etienne Bardet, Augustin Mervoyer, Benoit Piot, Brigitte Dreno, Olivier Malard.   

Abstract

BACKGROUND: Infiltrating squamous cell carcinoma (SCC) of the lower lip is a highly curable cancer. We retrospectively analyzed oncologic, functional, and cosmetic outcomes after interstitial low-dose rate brachytherapy at 58 Gy (50-62) of lower lip SCC treated in our institution.
METHODS: There were 89 patients (44 T1, 33 T2, 2 T3, and 10 after wedge-excision). All tumors were N0 at the time of treatment. We calculated survival rates and assessed functional and cosmetic results de visu.
RESULTS: After a median follow-up of 36 months (range, 9-127), 5-year local control rate was 95% and 5-year disease-free survival was 82%. Only 6 patients (5 T2 and 1 T3) developed secondary cervical nodal involvement. Sixty-one patients were reassessed and 11 patients presented mild functional troubles. Cosmetic results were good (77%) or fair (21%).
CONCLUSION: Brachytherapy provided a high local disease control rate, excellent functional results, and good cosmetic outcomes for SCCs of the lip. Risk of cervical node involvement was low with small tumors.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22495827     DOI: 10.1002/hed.22981

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

Review 1.  The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck.

Authors:  Małgorzata Wierzbicka; Anna Bartochowska; Vratislav Strnad; Primož Strojan; William M Mendenhall; Louis B Harrison; Alessandra Rinaldo; Puja Sahai; Susanne Wiegand; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-22       Impact factor: 2.503

2.  Adjuvant interstitial three-dimensional pulse-dose-rate-brachytherapy for lip squamous cell carcinoma after surgical resection.

Authors:  Artur Jan Chyrek; Grzegorz Mikołaj Biele Bielęda; Wojciech Maria Burchardt; Adam Chicheł; Piotr Andrzej Wojcieszek
Journal:  J Contemp Brachytherapy       Date:  2019-04-29

3.  Pulsed dose rate brachytherapy of lip cancer.

Authors:  Krystyna Serkies; Adam Ziemlewski; Tomasz Sawicki; Joanna Kamińska; Rafał Dziadziuszko
Journal:  J Contemp Brachytherapy       Date:  2013-09-20

4.  High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacer.

Authors:  Koji Masui; Hideya Yamazaki; Gen Suzuki; Daisuke Shimizu; Kanako Kawabata; Naoki Noguchi; Tadashi Takenaka; Ken Yoshida; Naoya Murakami; Masayuki Naito; Toshiro Yamamoto; Narisato Kanamura; Satoshi Komori; Akifumi Oshita; Jun Asai; Kei Yamada
Journal:  J Radiat Res       Date:  2020-05-22       Impact factor: 2.724

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.